Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 49

1.

Hematopoietic transplant-associated thrombotic microangiopathy: case report and review of diagnosis and treatments.

Chapin J, Shore T, Forsberg P, Desman G, Van Besien K, Laurence J.

Clin Adv Hematol Oncol. 2014 Sep;12(9):565-73. Review.

PMID:
25654478
2.

Podocyte dysfunction in atypical haemolytic uraemic syndrome.

Noris M, Mele C, Remuzzi G.

Nat Rev Nephrol. 2015 Apr;11(4):245-52. doi: 10.1038/nrneph.2014.250. Epub 2015 Jan 20. Review.

PMID:
25599621
3.

Complement regulators in human disease: lessons from modern genetics.

K Liszewski M, Atkinson JP.

J Intern Med. 2015 Mar;277(3):294-305. doi: 10.1111/joim.12338. Epub 2015 Jan 16. Review.

PMID:
25495259
4.

Natural history of thrombotic thrombocytopenic purpura and hemolytic uremic syndrome.

Wada H, Matsumoto T, Yamashita Y.

Semin Thromb Hemost. 2014 Nov;40(8):866-73. doi: 10.1055/s-0034-1395154. Epub 2014 Nov 6. Review.

PMID:
25377323
5.

A mechanistic approach to the diagnosis and management of atypical hemolytic uremic syndrome.

Tsai HM.

Transfus Med Rev. 2014 Oct;28(4):187-97. doi: 10.1016/j.tmrv.2014.08.004. Epub 2014 Sep 3. Review.

PMID:
25280590
6.

Role of monoclonal antibodies in the treatment of immune-mediated glomerular diseases.

Manrique J, Cravedi P.

Nefrologia. 2014 May 21;34(3):388-97. doi: 10.3265/Nefrologia.pre2014.Feb.12506. Epub 2014 Apr 10. Review. English, Spanish.

7.

Cardiovascular complications in atypical haemolytic uraemic syndrome.

Noris M, Remuzzi G.

Nat Rev Nephrol. 2014 Mar;10(3):174-80. doi: 10.1038/nrneph.2013.280. Epub 2014 Jan 14. Review.

PMID:
24419569
8.

CD46: the 'multitasker' of complement proteins.

Yamamoto H, Fara AF, Dasgupta P, Kemper C.

Int J Biochem Cell Biol. 2013 Dec;45(12):2808-20. doi: 10.1016/j.biocel.2013.09.016. Epub 2013 Oct 9. Review.

PMID:
24120647
9.

[Eculizumab for the treatment of atypical hemolytic uremic syndrome: case report and revision of the literature].

Vaisbich MH, Henriques Ldos S, Watanabe A, Pereira LM, Metran CC, Malheiros DA, Modanez F, Silva JD, Vieira S, Macedo AC, Massarope B, Furusawa EA, Schvartsman BG.

J Bras Nefrol. 2013 Jul-Sep;35(3):237-41. doi: 10.5935/0101-2800.20130037. Review. Portuguese.

10.

Complement factor H related proteins (CFHRs).

Skerka C, Chen Q, Fremeaux-Bacchi V, Roumenina LT.

Mol Immunol. 2013 Dec 15;56(3):170-80. doi: 10.1016/j.molimm.2013.06.001. Epub 2013 Jul 3. Review.

11.

Complement therapy in atypical haemolytic uraemic syndrome (aHUS).

Wong EK, Goodship TH, Kavanagh D.

Mol Immunol. 2013 Dec 15;56(3):199-212. doi: 10.1016/j.molimm.2013.05.224. Epub 2013 Jun 28. Review.

12.

Atypical haemolytic uraemic syndrome with underlying glomerulopathies. A case series and a review of the literature.

Manenti L, Gnappi E, Vaglio A, Allegri L, Noris M, Bresin E, Pilato FP, Valoti E, Pasquali S, Buzio C.

Nephrol Dial Transplant. 2013 Sep;28(9):2246-59. doi: 10.1093/ndt/gft220. Epub 2013 Jun 19. Review.

13.

Eculizumab in renal transplantation.

Legendre C, Sberro-Soussan R, Zuber J, Rabant M, Loupy A, Timsit MO, Anglicheau D.

Transplant Rev (Orlando). 2013 Jul;27(3):90-2. doi: 10.1016/j.trre.2013.04.002. Epub 2013 Jun 7. Review.

PMID:
23747093
14.

Complement activation in diseases presenting with thrombotic microangiopathy.

Meri S.

Eur J Intern Med. 2013 Sep;24(6):496-502. doi: 10.1016/j.ejim.2013.05.009. Epub 2013 Jun 4. Review.

PMID:
23743117
15.

Thrombotic thrombocytopenic purpura and the atypical hemolytic uremic syndrome: an update.

Tsai HM.

Hematol Oncol Clin North Am. 2013 Jun;27(3):565-84. doi: 10.1016/j.hoc.2013.02.006. Review.

PMID:
23714312
16.

The use of eculizumab in renal transplantation.

Barnett AN, Asgari E, Chowdhury P, Sacks SH, Dorling A, Mamode N.

Clin Transplant. 2013 May-Jun;27(3):E216-29. doi: 10.1111/ctr.12102. Epub 2013 Mar 21. Review.

PMID:
23516966
17.

Untying the knot of thrombotic thrombocytopenic purpura and atypical hemolytic uremic syndrome.

Tsai HM.

Am J Med. 2013 Mar;126(3):200-9. doi: 10.1016/j.amjmed.2012.09.006. Review.

PMID:
23410558
18.

[Partial mole and atypical preeclampsia: a case report and review of the literature].

Barrón Rodríguez JL, Piña Saucedo F, Clorio Carmona J, Fraire González FJ, Soto Ruíz OA.

Ginecol Obstet Mex. 2012 Dec;80(12):783-7. Review. Spanish.

PMID:
23405510
19.

STEC-HUS, atypical HUS and TTP are all diseases of complement activation.

Noris M, Mescia F, Remuzzi G.

Nat Rev Nephrol. 2012 Nov;8(11):622-33. doi: 10.1038/nrneph.2012.195. Epub 2012 Sep 18. Review.

PMID:
22986360
20.

A new era in the diagnosis and treatment of atypical haemolytic uraemic syndrome.

Westra D, Wetzels JF, Volokhina EB, van den Heuvel LP, van de Kar NC.

Neth J Med. 2012 Apr;70(3):121-9. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk